Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024
Provided By GlobeNewswire
Last update: Jul 31, 2024
Fosgonimeton mitigated amyloid-β-induced toxicity, lowered pTau levels and reduced disruption of protein clearance mechanisms that may contribute to pTau pathology
NASDAQ:ATHA (2/21/2025, 8:02:06 PM)
0.4341
-0.01 (-3.21%)
Find more stocks in the Stock Screener
